Trial in Progress: A Multicenter Phase Ib/II Study of Pelcitoclax (APG-1252) in Combination with Paclitaxel in Patients with Relapsed/refractory Small-Cell Lung Cancer (R/R SCLC).
Journal of Clinical Oncology（2021）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined